|
Name: Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
Type: Synthetic cannabinoid
AKA: 5F-EDMB-PINACA
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Ethyl 2-(1-(5-Fluoropentyl)-1H-Indazole-3-Carboxamido)-3,3-Dimethylbutanoate, a synthetic cannabinoid, was first synthesized in the 2010s. It is designed to mimic the effects of THC and interact with cannabinoid receptors. The compound's introduction reflects trends in synthetic cannabinoid development. Its potency and health risks have led to increased regulatory measures.
|
|
V. Legal Information
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate is a synthetic cannabinoid, often controlled under analog laws. In the U.S., it is regulated by the Federal Analog Act, reflecting its similarity to THC. Internationally, many countries have imposed strict controls to manage the abuse potential of synthetic cannabinoids. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate is a synthetic cannabinoid that produces effects similar to THC, including euphoria, altered perception, and increased appetite. It can lead to drowsiness, elevated heart rate, and anxiety. Overdose risks include severe agitation and cardiovascular issues. Safe use requires careful dosing. Recent research focuses on its psychoactive properties and potential for abuse.  |
|
VII. Psychological Effects
This synthetic cannabinoid induces euphoria and altered perception. Immediate effects include mood enhancement and cognitive distortion. Long-term use may result in severe anxiety, psychosis, and cognitive impairments. Recent studies highlight its high abuse potential and significant psychological risks associated with synthetic cannabinoids.
 |
|
VIII. Culture
This synthetic cannabinoid mimics the effects of THC, producing psychoactive and sedative effects, classifying it as a downer. Short-term use can cause euphoria, altered perception, and relaxation, while long-term use may lead to cognitive impairment and psychological dependence. Overdose can result in severe anxiety, hallucinations, and cardiovascular issues. Safe use is not well-established, but lower dosages are recommended. Recent studies warn of unpredictable potency and health risks. Physical signs include red eyes, dry mouth, and altered mental state.
 |